Published in Eur Urol on December 08, 2014
Randomized Trial Comparing Robotic and Open Radical Cystectomy | NCT01076387
Comparing Rectus Sheath Catheter to Epidural Post Cystectomy | NCT02572804
Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care? World J Urol (2015) 0.96
Open radical cystectomy: still the gold standard for muscle invasive bladder cancer. World J Urol (2015) 0.82
"The devil is in the details": randomized trial of robotic versus open radical cystectomy. Eur Urol (2015) 0.80
Optimal management of muscle-invasive bladder cancer - a review. Res Rep Urol (2015) 0.79
Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelines. Nat Rev Urol (2016) 0.78
The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology. World J Urol (2015) 0.77
Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy. Nat Rev Urol (2015) 0.76
Enhanced Recovery after Urological Surgery: A Contemporary Systematic Review of Outcomes, Key Elements, and Research Needs. Eur Urol (2016) 0.76
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016). Clin Transl Oncol (2016) 0.75
Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10-year, single center experience. Springerplus (2015) 0.75
Radical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian cohort. Int Braz J Urol (2016) 0.75
Systematic review and meta-analysis of randomised trials of perioperative outcomes comparing robot-assisted versus open radical cystectomy. BMC Urol (2016) 0.75
Understanding the roles of randomized trials for robotic prostatectomy. Ann Transl Med (2016) 0.75
Open versus robotic cystectomy: Comparison of outcomes. Investig Clin Urol (2016) 0.75
Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer. Nat Rev Urol (2016) 0.75
Treatment of bladder cancer in the elderly. Investig Clin Urol (2016) 0.75
The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial. Ann Surg (2016) 0.75
A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy. Int Braz J Urol (2016) 0.75
The surgeon makes the difference, not the instrument used. Eur Urol (2015) 0.75
The Impact of Health Literacy on Surgical Outcomes Following Radical Cystectomy. J Health Commun (2016) 0.75
Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery? Urol Clin North Am (2015) 0.75
How to optimally manage elderly bladder cancer patients? Transl Androl Urol (2016) 0.75
Re: Comparing Open Radical Cystectomy and Robot-Assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. J Urol (2015) 0.75
Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence? World J Urol (2016) 0.75
Complications and health-related quality of life after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis of four RCTs. Syst Rev (2017) 0.75
Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era. World J Urol (2016) 0.75
Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea. J Korean Med Sci (2017) 0.75
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study. Eur Urol Focus (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA (2002) 6.21
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol (2008) 5.64
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98
Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol (2004) 4.51
Quality of complication reporting in the surgical literature. Ann Surg (2002) 4.21
A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med (2014) 2.98
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol (2008) 2.83
Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol (2013) 2.74
Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol (2009) 2.68
Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy. Eur Urol (2012) 2.49
Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients. J Urol (2014) 2.34
Analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system. Urology (2010) 2.29
Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer (2000) 2.16
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol (2011) 2.14
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol (2007) 1.84
Matched comparison of robotic-assisted and open radical cystectomy. Urology (2012) 1.84
Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States. Eur Urol (2014) 1.82
Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int (2003) 1.73
Cost analysis of robotic versus open radical cystectomy for bladder cancer. J Urol (2009) 1.66
The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. J Urol (2012) 1.58
Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer (2006) 1.53
Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes. J Urol (2007) 1.35
Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU Int (2011) 1.23
Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute. Urology (2007) 1.21
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A (2011) 1.09
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy. BJU Int (2011) 0.99
Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. J Urol (2004) 0.95
The lymph node yield during robot-assisted radical cystectomy. BJU Int (2008) 0.94
The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer. World J Urol (2008) 0.90
Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC. BJU Int (2011) 0.87
Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer? Curr Opin Urol (2009) 0.84
An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy. Eur Urol (2015) 3.17
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study. Eur Urol (2015) 2.41
Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy. Eur Urol (2015) 1.48
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol (2016) 1.41
The role and timing of palliative medicine consultation for women with gynecologic malignancies: association with end of life interventions and direct hospital costs. Gynecol Oncol (2013) 0.92
Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes. Eur Urol (2015) 0.83
A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort. Eur Urol (2015) 0.82
Preoperative predictive model of recovery of urinary continence after radical prostatectomy. BJU Int (2015) 0.80
Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically. World J Urol (2016) 0.77
Re: whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Eur Urol (2015) 0.75
Low yield of surveillance imaging after surgery for T1 kidney cancer. World J Urol (2015) 0.75
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol (2017) 0.75
Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063). Bladder Cancer (2017) 0.75
Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols. BJU Int (2015) 0.75
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma. Eur Urol Focus (2017) 0.75
Commentary on Aschmann et al: How do we incorporate harms in analyses of randomized trials? Clin Trials (2022) 0.75
Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Surgery in Low-risk Patients? Eur Urol (2017) 0.75
Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial. Eur Urol (2017) 0.75
Idiographic quality of life assessment before radical cystectomy. Psychooncology (2015) 0.75
European urology: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review. Eur Urol (2014) 0.75
The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy. Eur Urol Focus (2017) 0.75
Male Neobladder. Urol Clin North Am (2018) 0.75
Prognostic Value of TERT Alterations and Mutational and Copy Number Alteration Burden in Urothelial Carcinoma. Eur Urol Focus (2017) 0.75
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma. Eur Urol Focus (2016) 0.75
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. Eur Urol Focus (2017) 0.75
Implementing a Multimodal Prehabilitation Program to Radical Cystectomy in a Comprehensive Cancer Center: A Pilot Study to Assess Feasibility and Outcomes. Urol Nurs (1) 0.75
Topography of Prostate Cancer Recurrence After Radiation Therapy: A Detailed Mapping Study of Salvage Radical Prostatectomy Specimens. Eur Urol (2017) 0.75
Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma. Eur Urol Focus (2016) 0.75
Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. Eur Urol (2017) 0.75
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples. Eur Urol Focus (2016) 0.75